Search PubMed⌕ Search

Biomedical subjects

L Ford

Publications and source records attributed to L Ford.

76 records · Page 5Linked to original sources
PubMedDate not supplied

Assessing smoke-free workplaces in Wisconsin municipal and county government buildings, 1997.

Passive smoke has been shown to cause cancer and heart disease in humans. We surveyed all Wisconsin cities and villages in 1997 to determine their clean indoor air policies in government-owned buildings. By 1997, 62% of cities and villages and 100% of counties had enacted a clean indoor air ordinance or policy. Smoking is completely banned in 26% of all city and village buildings and 49% of county buildings in the state. This survey shows that an increasing proportion of government worksites in Wisconsin are enacting clean indoor air policies to protect their employees and the public from the health effects of passive smoke.

Humans↗
PubMedDate not supplied

Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.

Using data collected as part of a larger evaluation of the National Cancer Institute-funded Community Clinical Oncology Program (CCOP), this paper examines the degree to which selected community, interorganizational, and structural characteristics associated with accrual to cancer treatment protocols share equal importance in accruing patients to cancer prevention and control research protocols. Analysis reveals that there are similarities in the factors that prove to be effective for accrual to both types of protocols; however, the two are not isomorphic. CCOP structure was an important predictor of treatment accrual but was not significant for cancer control accrual. Variables measuring the community health resources available to the CCOP were not significant for either treatment or cancer prevention and control research accrual when CCOP structure and interaction with participating research bases were considered. Only CCOP interaction with participating research bases was a significant predictor of both treatment and cancer prevention and control research accrual. The policy implications of these findings are discussed.

Clinical Protocols↗
PubMedDate not supplied

Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.

Cancer prevention and control involves a diverse spectrum of activities that range from preventing the disease to providing rehabilitation to its survivors. The range of activities included within the definition of cancer prevention and control makes it difficult to determine factors that would predict accrual to specific cancer prevention and control trials. The participation of 36 CCOP organization in the National Cancer Institute-sponsored Breast Cancer PRevention TRial (BCPT) presented the opportunity to assess the ability of Community Clinical Oncology Program (CCOPs) to enroll subjects in one of the nation's first large-scale cancer prevention trials and to compare characteristics of CCOP accrual to the BCPT with factors associated with accrual by CCOPs to cancer treatment and other cancer prevention and control clinical trials. Although representing only 13% of participating health care organizations, CCOPs presently contribute nearly 30% of total BCPT accrual. Comparison of regression models representing accrual to treatment, cancer control, and chemoprevention (i.e., BCPT) protocols shows similar predictors between treatment and chemoprevention models. Cancer control models, however, did not share similar predictors. Thus, accrual to chemoprevention trials is associated, to a greater extent, with the characteristics that facilitate accrual to treatment trials rather than to cancer control trials. Results have implications for the planning and ongoing management of cancer treatment, control, and chemoprevention clinical trials.

Antineoplastic Agents↗